Autor: |
Tamer Selen, Mehmet Deniz Ayli, Cagdas Kucukerdogan, Gülay Ulusal Okyay, Hatice Sahin, Ebru Gok Oguz |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Journal of Clinical and Diagnostic Research, Vol 15, Iss 8, Pp OC27-OC30 (2021) |
ISSN: |
2249-782X |
DOI: |
10.7860/jcdr/2021/49065.15212 |
Popis: |
Introduction: The level of 25-hydroxyvitamin D3 is an independent predictor of disease progression and death in Chronic Kidney Disease (CKD) patients. However, there are insufficient data to evaluate the possible effects of plasma 25(OH)D3 levels on the prognosis of Focal Segmental Glomerulosclerosis (FSGS). Aim: To analyse the relationship between renal prognosis and serum 25(OH)D3 status in FSGS. Materials and Methods: The study was conducted on 56 patients, who were followed-up for at least one year and diagnosed with primary FSGS. Participants were grouped according to their baseline 25(OH)D3 levels (≤15 or >15 ng/mL) and treatment response at the end of one year (remission group or no remission group) was evaluated. Results: Mean age of the 56 participants was 44±13.92 years and 27 (48.2%) were male. Remission achievement in the first year was significantly higher and interstitial fibrosis was significantly lower for the group with a 25(OH)D3 above >15 ng/ mL (p |
Databáze: |
OpenAIRE |
Externí odkaz: |
|